Vericel Net Income From Continuing Ops from 2010 to 2026
| VCEL Stock | USD 38.09 0.08 0.21% |
Net Income From Continuing Ops | First Reported 2000-09-30 | Previous Quarter -553 K | Current Value 5.1 M | Quarterly Volatility 5.1 M |
Check Vericel Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vericel Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.6 M, Interest Expense of 741.4 K or Total Revenue of 286.4 M, as well as many indicators such as Price To Sales Ratio of 9.67, Dividend Yield of 0.0 or PTB Ratio of 4.46. Vericel financial statements analysis is a perfect complement when working with Vericel Corp Valuation or Volatility modules.
Vericel | Net Income From Continuing Ops | Build AI portfolio with Vericel Stock |
Historical Net Income From Continuing Ops data for Vericel Corp serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Vericel Corp Ord represents a compelling investment opportunity.
Latest Vericel Corp's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Vericel Corp Ord over the last few years. It is Vericel Corp's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vericel Corp's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Vericel Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (10,124,976) | |
| Coefficient Of Variation | (123.53) | |
| Mean Deviation | 9,794,852 | |
| Median | (15,622,000) | |
| Standard Deviation | 12,507,451 | |
| Sample Variance | 156.4T | |
| Range | 42M | |
| R-Value | 0.83 | |
| Mean Square Error | 52.6T | |
| R-Squared | 0.68 | |
| Significance | 0.000041 | |
| Slope | 2,049,814 | |
| Total Sum of Squares | 2503T |
Vericel Net Income From Continuing Ops History
About Vericel Corp Financial Statements
Vericel Corp investors utilize fundamental indicators, such as Net Income From Continuing Ops, to predict how Vericel Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 11.9 M | 12.5 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Vericel Corp Correlation against competitors. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Vericel Corp assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 0.476 | Earnings Share 0.26 | Revenue Per Share | Quarterly Revenue Growth 0.166 | Return On Assets |
Investors evaluate Vericel Corp Ord using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Vericel Corp's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Vericel Corp's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Vericel Corp's market price signifies the transaction level at which participants voluntarily complete trades.